Amandine Conte-Daban

How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study

P. Faller, C. Hureau, A. Conte-Daban, 2016, Dalton transactions.

A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

S. Sayen, E. Guillon, C. Aparicio, 2017, Chemistry.

Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

P. Faller, C. Hureau, C. Esmieu, 2019, Inorganic chemistry.

Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level

C. Hureau, E. Atrián-Blasco, A. Conte-Daban, 2017, Dalton transactions.

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides

S. Sayen, E. Guillon, P. Faller, 2016, Inorganic chemistry.

A Metallo Pro-Drug to Target CuII in the Context of Alzheimer's Disease.

C. Policar, C. Hureau, R. Guillot, 2018, Chemistry.

Link between Affinity and Cu(II) Binding Sites to Amyloid-β Peptides Evaluated by a New Water-Soluble UV-Visible Ratiometric Dye with a Moderate Cu(II) Affinity.

S. Sayen, E. Guillon, V. Borghesani, 2017, Analytical chemistry.